ETH269 8 mg (Doxazosin Mesylate 8 mg)
Pill with imprint ETH269 8 mg is Blue, Elliptical/Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Ethex Corporation.
Doxazosin is used in the treatment of raynaud's syndrome; benign prostatic hyperplasia; high blood pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ETH269 8 mg



Doxazosin Mesylate
- Imprint
- ETH269 8 mg
- Strength
- 8 mg
- Color
- Blue
- Size
- 12.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ethex Corporation
- National Drug Code (NDC)
- 58177-0269 (Discontinued)
More about doxazosin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (51)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: alpha-adrenoreceptor antagonists
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.